Trial
NCT00811356
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Malaria
Intervention
GSK932121
Why stopped
safety issues (toxicity)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-03